Psychosocial aspects of diabetes mellitus (Part 2): S2-guideline psychosocial aspects of diabetes - Long version;Psychosoziales und Diabetes (Teil 2): S2-Leitlinie Psychosoziales und Diabetes - Langfassung

Diabetologie und Stoffwechsel

Volumn 8, Issue 4, 2013, Pages 292-324

  Kulzer, B ^a   Albus, C ^b   Herpertz, S ^c   Kruse, J ^d   Lange, K ^e   Lederbogen, F ^f   Petrak, F ^c  

^a Forschungsinstitut Diabetes Akademie Bad Mergentheim FIDAM GmbH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; PRACTICE GUIDELINE; SOCIAL PSYCHOLOGY;

EID: 84883461750     PISSN: 18619002     EISSN: 18619010     Source Type: Journal    
DOI: 10.1055/s-0033-1335889     Document Type: Article

References (513)

1. Herpertz S., Petrak F., Albus C. et al. Evidenzbasierte Diabetes-Leitlinie DDG. Psychosoziales und Diabetes mellitus. Diabetes und Stoffwechsel: 2003; 12 02 69 94
2. WHO - World Health Organization Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F). Diagnostische Kriterien für Forschung und Praxis. 4. überarbeitete Aufl Bern Huber: 2006
3. DIMDI Deutsches Institut für Medizinische Dokumentation und Information Die Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme. 10. Revision, German Modification (ICD-10-GM): 2012; http://www.dimdi.de/static/de/klassi/icd-10-gm/index.htm zuletzt aufgerufen am 10.4.2013
4. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Programm für Nationale VersorgungsLeitlinien. Methoden-Report. 2010; 4. Aufl http://www.versorgungsleitlinien.de/methodik/ reports zuletzt aufgerufen am 10.4.2013
5. CDA Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes: 2008; 32 01 S1 S201 EK IV
6. NCC-CC Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update). London Royal College of Physicians: 2008; EK IV
7. Funnell M. M., Brown T. L., Childs B. P. et al. National Standards for diabetes self-management education. Diab Care: 2011; 34 01 S89 S96 EK IV
8. IDF - International Diabetes Federation Global guidelines for type 2 diabetes. Brussels International Diabetes Federation: 2012;. EK IV
9. Norris S. L., Engelgau M. M., Venkat N. KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diab Care: 2001; 24 03 561 587 EK Ia
10. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ: 2002; 325 7367 746 EK Ib
11. Amsberg S., Anderbro T., Wredling R. et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients - a randomized controlled trial. Patient Educ Couns: 2009; 77 01 72 80 EK Ib
12. Mühlhauser I., Bruckner I., Berger M. et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Duesseldorf Study. Diabetologia: 1987; 30 09 681 690 EK IIa
13. Jörgens V., Grüßer M. Behandlungs- und Schulungsprogramm für intensivierte Insulintherapie. 5. Aufl Köln Deutscher Ärzte-Verlag: 2009
14. Mühlhauser I., Jörgens V., Berger M. et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia: 1983; 25 06 470 476 EK IIb
15. Pieber T. R., Brunner G. A., Schnedl W. J. et al. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diab Care: 1995; 18 05 625 630 EK IIb
16. Feulner-Krakow G., Krakow D. LINDA - Diabetes-Selbstmanagementschulung. Das Selbstmanagement-Programm für Menschen mit Typ-1- oder Typ-2-Diabetes. Forchheim: Diabetespraxis Forchheim: 1997; 1. Aufl
17. Krakow D., Feulner-Krakow G., Giese M. et al. Evaluation der LINDA Diabetes-Selbstmanagementschulung. Diabetes und Stoffwechsel: 2004; 13 02 77 89 EK IIb
18. Brown S. A. Studies of educational interventions and outcomes in diabetic adults: a meta-analysis revisited. Patient Educ Couns: 1990; 16 03 189 215 EK IIa
19. Deakin T., McShane C. E., Cade J. E. et al. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews: 2005; 2 CD003417 EK Ib
20. Ellis S. E., Speroff T., Dittus R. S. et al. Diabetes patient education: a meta-analysis and meta-regression. Patient Educ Couns: 2004; 52 01 97 105 EK Ia
21. Chodosh J., Morton S. C., Mojica W. et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med: 2005; 143 06 427 438 EK Ia
22. Minet L., Moller S., Vach W. et al. Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials. Patient Educ Couns: 2010; 80 01 29 41 EK Ia
23. Hörnsten A., Stenlund H., Lundman B. et al. Improvements in HbA1c remain after 5 years - a follow up of an educational intervention focusing on patients' personal understandings of type 2 diabetes. Diabetes Research and Clinical Practice: 2008; 81 01 50 55 EK Ib
24. Cochran J., Conn V. S. Meta-analysis of Quality of Life Outcomes Following Diabetes Self-management Training. Diabetes Educ: 2008; 34 05 815 823 EK IIa
25. Steed L., Cooke D., Newman S. A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus. Patient Educ Couns: 2003; 51 01 5 15 EK Ib
26. Berger M., Grüsser M., Jörgens V. et al. Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die nicht Insulin spritzen. Köln Deutscher Ärzteverlag: 2010
27. Kronsbein P., Jorgens V., Muhlhauser I. et al. Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet: 1988; 2 8625 1407 1411 EK IIa
28. Grüsser M., Bott U., Ellermann P. et al. Evaluation of a structured treatment and teaching program for non-insulin-treated type II diabetic outpatients in Germany after the nationwide introduction of reimbursement policy for physicians. Diab Care: 1993; 16 09 1268 1275 EK IIb
29. Berger M., Grüsser M., Jörgens V. et al. Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die Insulin spritzen (konventionelle Insulintherapie). Köln Deutscher Ärzteverlag: 2010
30. Grüsser M., Hartmann P., Schlottmann N. et al. Structured treatment and teaching programme for type 2 diabetic patients on conventional insulin treatment: evaluation of reimbursement policy. Patient Educ Couns: 1996; 29 01 123 130 EK IIb
31. Müller U. A., Müller R., Starrach A. et al. Should insulin therapy in type 2 diabetic patients be started on an out- or inpatient basis? Results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital. Diabetes Metab: 1998; 24 03 251 255 EK IIb
32. Berger M., Grüsser M., Jörgens V. Behandlungs- und Schulungsprogramm für Typ-2-Diabetiker, die Normalinsulin spritzen (praeprandiale Insulintherapie). 2011 Köln Deutscher Ärzteverlag
33. Kalfhaus J., Berger M. Insulin treatment with preprandial injections of regular insulin in middle-aged type 2 diabetic patients. A two years observational study. Diabetes Metab: 2000; 26 03 197 201 EK IIb
34. Kulzer B., Hermanns N., Maier B. et al. MEDIAS 2 - Mehr Diabetes Selbstmanagement für Typ 2. Ein Schulungs- und Behandlungsprogramm für Menschen mit nicht-insulinpflichtigem Typ-2-Diabetes (MEDIAS 2 Basis). 5. Aufl Mainz Kirchheim-Verlag: 2011
35. Kulzer B., Hermanns N. Mehr Diabetes Selbstmanagement Typ 2": Ein neues Schulungs- und Behandlungsprogramm für Menschen mit nicht-insulinpflichtigem Typ-2-Diabetes. Praxis Klinische Verhaltensmedizin und Rehabilitation: 2001; 14 54 129 136 EK Ib
36. Kulzer B., Hermanns N., Reinecker H. et al. Effects of self-management training in Type 2 diabetes: a randomized, prospective trial. Diabet Med: 2007; 24 04 415 423 EK Ib
37. Kulzer B., Hermanns N., Maier B. et al. MEDIAS 2 - Mehr Diabetes Selbstmanagement für Typ 2. Ein Schulungs- und Behandlungsprogramm für Menschen mit Typ-2-Diabetes und intensivierter Insulintherapie (MEDIAS 2 ICT). 1. Aufl Mainz Kirchheim-Verlag: 2012
38. Hermanns N., Kulzer B., Maier B. et al. The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetes. Patient Educ Couns: 2012; 86 02 226 232 EK Ib
39. Brinkmeier U., Frank M., Tewes U. Diabetes II im Gespräch - Therapieprogramm für Typ-II-Diabetiker, die nicht Insulin spritzen. Heidelberg Spektrum Akademischer Verlag: 1998
40. Hartwig A., Tewes U., Brinkmeier U. Die Bedeutung der fachlichen Qualifikation für den Erfolg in der Patientenschulung am Beispiel eines Programms zur verhaltensmedizinischen Behandlung von adipösen Typ-II-Diabetikern. Zeitschrift für Medizinische Psychologie: 1999; 8 02 65 72 EK III
41. Brinkmeier U., Frank M., Tewes U. et al. Diabetes & Verhalten - Schulungsprogramm für Typ-2-Diabetiker, die Insulin spritzen. 1. Aufl Mainz Kirchheim-Verlag: 2009
42. Tewes A., Frank M., Tegtbur U. et al. Patientenzentrierte verhaltensmedizinische Schulung - Patienten mit insulinpflichtigem Typ-2-Diabetes profitieren unabhängig von ihrem Bildungsstand. MMW Fortschr Med: 2006; 148 15 49 EK IIb
43. Tewes A., Frank M., Tegtbur U. et al. Insulinpflichtiger Typ-2-Diabetes: Patientenzentrierte Schulung verbessert die Stoffwechsellage. Dtsch Arztebl: 2006; 103 06 A341 A345 EK IIb
44. Zeyfang A., Feucht I. Fit bleiben und älter werden mit Diabetes. Strukturiertes Schulungsprogramm (SGS) für Typ-2-Diabetiker im höheren Lebensalter. Elsevier 2007
45. Braun A. K., Kubiak T., Kuntsche J. et al. SGS: a structured treatment and teaching programme for older patients with diabetes mellitus - a prospective randomised controlled multi-centre trial. Age Ageing: 2009; 38 04 390 396 EK Ib
46. Cox D. J., Gonder-Frederick L., Ritterband L. et al. Blood Glucose Awareness Training: What Is It, Where Is It, and Where Is It Going? Diabetes Spectr: 2006; 19 01 43 49 EK IIb
47. Fehm-Wolfsdorf G., Kerner W., Peters A. Blutglukosewahrnehmungstraining für Typ 1 Diabetiker (BGAT). (deutsche Version des Blood Glucose Awarness Training" von Cox et al.). 1. Aufl Lübeck Lübecker Institut für Verhaltensmedizin: 1997
48. Schächinger H., Hegar K., Hermanns N. et al. Randomized controlled clinical trial of Blood Glucose Awareness Training (BGAT III) in Switzerland and Germany. J Behav Med: 2005; 28 06 587 594 EK Ib
49. Kulzer B., Hermanns N., Kubiak T. et al. HyPOS - Unterzuckerungen besser wahrnehmen, vermeiden und bewältigen. Ein strukturiertes Schulungs- und Behandlungsprogramm für insulinpflichtige Diabetiker mit Hypoglykämieproblemen. Mainz Kirchheim: 2006
50. Kulzer B., Hermanns N., Krichbaum M. HyPOS stationär - Unterzuckerungen besser wahrnehmen, vermeiden und bewältigen. Problemspezifisches Gruppenschulungs- und Behandlungsprogramm für insulinbehandelte Diabetiker mit Hypoglykämieproblemen zur Durchführung im stationären Setting. Mainz Kirchheim: 2008
51. Hermanns N., Kulzer B., Kubiak T. et al. The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes. Diabetes Metab Res Rev: 2007; 23 07 528 538 EK Ib
52. Hermanns N., Kulzer B., Krichbaum M. et al. Long-Term Effect of an Education Program (HyPOS) on the Incidence of Severe Hypoglycemia in Patients With Type 1 Diabetes. Diab Care: 2010; 33 03 e36 EK Ib
53. Dorresteijn J. A., Kriegsman D. M., Assendelft W. J. et al. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev: 2010; 05 CD001488 EK Ia
54. Malone J. M., Snyder M., Anderson G. et al. Prevention of amputation by diabetes education. American Journal of Surgery: 1989; 158 520 523 EK Ib
55. Lincoln N. B., Radford K. A., Game F. L. et al. Education for secondary prevention of foot ulcers in people with diabetes: a randomised controlled trial. Diabetologia: 2008; 51 11 1954 1961 EK Ib
56. Bloomgarden Z. T., Karmally W., Metzger M. J. et al. Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diab Care: 1987; 10 03 263 272 EK Ib
57. Ronnemaa T., Hamalainen H., Toikka T. et al. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects. Diab Care: 1997; 20 12 1833 1837 EK Ib
58. Anlauf-Wilhelm B., Fisch R., Gralki A. et al. Den Füssen zu liebe (BARFUSS) - Strukturiertes Behandlungs- und Schulungsprogramm für Menschen mit Diabetes und einem diabetischen Fußsyndrom. VDBD 1999
59. Hirsch A., Taiyeva O., Clever H-U. Evaluation der Schulung Den Füßen zuliebe" für Risikopatienten nach 6 Monaten. Diabetes und Stoffwechsel: 2004; 13 02 67 76 EK IIb
60. Boule N. G., Kenny G. P., Haddad E. et al. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia: 2003; 46 08 1071 1081 EK Ia
61. DiLoreto C., Fanelli C., Lucidi P. et al. Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects. Diab Care: 2003; 26 02 404 408 EK Ia
62. Siegrist M., Zimmer P., Klare W. R. et al. DiSko: wie Diabetiker zum Sport kommen. Arbeitsgemeinschaft Diabetes und Sport der DDG, 2004
63. Siegrist M., Zimmer P., Klare W. R. et al. Einmalige Übungsstunde verändert das Aktivitätsverhalten bei Typ-2-Diabetikern. Diabetes, Stoffwechsel und Herz: 2007; 16 04 257 261 EK IIb
64. Siegrist M., Zimmer P., Klare W. R. et al. Bewegung macht Schule - Wirksamkeit und Umsetzbarkeit der Bewegungsschulung DiSko bei Typ-2-Diabetikern. Diabetologie und Stoffwechsel: 2009; 4 02 118 122 EK IIb
65. Duke S. A., Colagiuri S., Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev: 2009; 01 CD005268 EK Ib
66. Boren S. A., Fitzner K. A., Panhalkar P. S. et al. Costs and benefits associated with diabetes education: a review of the literature. Diabetes Educ: 2009; 35 01 72 96 EK Ia
67. Gillett M., Dallosso H. M., Dixon S. et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ: 2010; 341 c4093 EK Ib
68. Dubois B., Feldman H. H., Jacova C. et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol: 2010; 9 11 1118 1127
69. Petersen R. C., Roberts R. O., Knopman D. S. et al. Mild cognitive impairment: ten years later. Arch Neurol: 2009; 66 12 1447 1455
70. Petersen R. C. Mild cognitive impairment as a diagnostic entity. J Intern Med: 2004; 256 03 183 194 EK IV
71. Winblad B., Palmer K., Kivipelto M. et al. Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med: 2004; 256 03 240 246 EK IV
72. Draelos M. T., Jacobson A. M., Weinger K. et al. Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med: 1995; 98 02 135 144 EK IIa
73. Gonder-Frederick L. A., Zrebiec J. F., Bauchowitz A. U. et al. Cognitive function is disrupted by both hypo- and hyperglycemia in school-aged children with type 1 diabetes: a field study. Diab Care: 2009; 32 06 1001 1006 EK IIa
74. Musen G., Simonson D. C., Bolo N. R. et al. Regional brain activation during hypoglycemia in type 1 diabetes. J Clin Endocrinol Metab: 2008; 93 04 1450 1457 EK IIa
75. Wright R. J., Frier B. M. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev: 2008; 24 05 353 363 EK IIa
76. Cryer P. E. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. NEJM: 2004; 350 22 2272 2279 EK IIa
77. Warren R. E., Deary I. J., Frier B. M. The symptoms of hyperglycaemia in people with insulin-treated diabetes: classification using principal components analysis. Diabetes Metab Res Rev: 2003; 19 05 408 414 EK IIa
78. Strachan M. W. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia. Diabet Med: 2011; 28 02 141 147 EK IIa
79. Cox D. J., Kovatchev B. P., Gonder-Frederick L. A. et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diab Care: 2005; 28 01 71 77 EK IIa
80. Cosway R., Strachan M. W., Dougall A. et al. Cognitive function and information processing in type 2 diabetes. Diabet Med: 2001; 18 10 803 810 EK IIa
81. Sommerfield A. J., Deary I. J., Frier B. M. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diab Care: 2004; 27 10 2335 2340 EK IIa
82. Ritchie K., Carrière I., Ritchie C. W. et al. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ: 2010; 341 c3885 EK III
83. Ryan C. M., Geckle M. O., Orchard T. J. Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia: 2003; 46 07 940 948 EK III
84. Brands A. M., Biessels G. J., de Haan E. H. et al. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diab Care: 2005; 28 03 726 735 EK Ia
85. Jacobson A. M., Musen G., Ryan C. M. et al. Long-term effect of diabetes and its treatment on cognitive function. NEJM: 2007; 356 18 1842 1852 EK Ib
86. Brands A. M., van den Berg E., Manschot S. M. et al. A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. J Int Neuropsychol Soc: 2007; 13 02 288 297 EK III
87. Christman A. L., Vannorsdall T. D., Pearlson G. D. et al. Cranial volume, mild cognitive deficits, and functional limitations associated with diabetes in a community sample. Arch Clin Neuropsychol: 2010; 25 01 49 59 EK III
88. Reijmer Y. D., van den Berg E., Ruis C. et al. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev: 2010; 26 07 507 519 EK III
89. Gregg E. W., Yaffe K., Cauley J. A. et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med: 2000; 160 02 174 180 EK III
90. Amieva H., Jacqmin-Gadda H., Orgogozo J. M. et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain: 2005; 128 05 1093 1101 EK III
91. van den Berg E., Kloppenborg R. P., Kessels R. P. et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. Biochim Biophys Acta: 2009; 1792 05 470 481 EK III
92. Elias P. K., Elias M. F., D'Agostino R. B. et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diab Care: 1997; 20 09 1388 1395 EK III
93. Lindeman R. D., Romero L. J., LaRue A. et al. A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey. Diab Care: 2001; 24 09 1567 1572 EK III
94. EuroCoDe - European Collaboration on Dementia: 2010; Prevalence of dementia in Europe. Demenz-Zahlen Stand 2006 gemäß Alzheimer Europe. European Collaboration on Dementia. (http://www.alzheimer-europe.org/Research/ European-Collaboration-on-Dementia/Prevalence-of-dementia/Prevalence-of- dementia-in-Europe; zuletzt aufgerufen am 6.12.2012) EK III
95. Weyerer S. Altersdemenz. Gesundheitsberichterstattung des Bundes (Heft 28). Berlin Robert Koch-Institut EK III: 2005
96. Ferri C. P., Prince M., Brayne C. et al. Global prevalence of dementia: a Delphi consensus study. Lancet: 2005; 366 9503 2112 2117 EK IV
97. Biessels G. J., Staekenborg S., Brunner E. et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol: 2006; 5 01 64 74 EK III
98. Toro P., Schonknecht P., Schroder J. Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany. J Alzheimers Dis: 2009; 16 04 687 691 EK III
99. Cukierman T., Gerstein H. C., Williamson J. D. Cognitive decline and dementia in diabetes - systematic overview of prospective observational studies. Diabetologia: 2005; 48 12 2460 2469 EK III
100. Sima A. A. Encephalopathies: the emerging diabetic complications. Acta Diabetol: 2010; 47 04 279 293 EK III
101. Young S. E., Mainous A. G. III et al. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diab Care: 2006; 29 12 2688 2693 EK III
102. van den Berg E., Dekker J. M., Nijpels G. et al. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord: 2008; 26 03 261 269 EK III
103. Ryan C. M., Williams T. M., Finegold D. N. et al. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia: 1993; 36 04 329 334 EK III
104. Lesage S. R., Mosley T. H., Wong T. Y. et al. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology: 2009; 73 11 862 868 EK III
105. Ding J., Strachan M. W., Reynolds R. M. et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes: 2010; 59 11 2883 2889 EK III
106. Ferguson S. C., Blane A., Perros P. et al. Cognitive ability and brain structure in type 1 diabetes. Relation to Microangiopathy and preceding severe hypoglycemia. Diabetes: 2003; 52 149 156 EK III
107. Saczynski J. S., Jonsdottir M. K., Garcia M. E. et al. Cognitive impairment: an increasingly important complication of type 2 diabetes: the age, gene/environment susceptibility - Reykjavik study. Am J Epidemiol: 2008; 168 10 1132 1139 EK III
108. Dore G. A., Elias M. F., Robbins M. A. et al. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study. Diabetologia: 2009; 52 12 2551 2560 EK III
109. Sinclair A. J., Girling A. J., Bayer A. J. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract: 2000; 50 03 203 212 EK III
110. Baliga B. S., Weinberger J. Diabetes and stroke: part one - risk factors and pathophysiology. Curr Cardiol Rep: 2006; 8 01 23 28 EK III
111. Furie K., Inzucchi S. E. Diabetes mellitus, insulin resistance, hyperglycemia, and stroke. Curr Neurol Neurosci Rep: 2008; 8 01 12 19 EK III
112. Sander D., Sander K., Poppert H. Review: Stroke in type 2 diabetes. Br J Diabetes Vasc Dis: 2008; 8 05 222 229 EK III
113. Schoenle E. J., Schoenle D., Molinari L. et al. Impaired intellectual development in children with Type I diabetes: association with HbA (1c), age at diagnosis and sex. Diabetologia: 2002; 45 01 108 114 EK III
114. Bruce D. G., Davis W. A., Casey G. P. et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia: 2009; 52 09 1808 1815 EK III
115. Whitmer R. A., Karter A. J., Yaffe K. et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA: 2009; 301 15 1565 1572 EK III
116. ADA Standards of Medical Care in Diabetes - 2011. Diab Care: 2011; 34 01 S11 S61 EK IV
117. Ko S. B., Bae H. J., Lee S. H. et al. Teaching NeuroImage: hippocampal involvement in a patient with hypoglycemic coma. Neurology: 2008; 71 20 e63 EK IV
118. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Neurologie (DGN), in Zusammenarbeit mit der Deutschen Alzheimer Gesellschaft e.V. (DAlzG) Selbsthilfe Demenz. S3-Leitlinie Demenzen. 2009; http://www.awmf.org/uploads/tx- szleitlinien/038-013-S3-Demenzen-lang-11-2009-11-2011.pdf zuletzt aufgerufen am 10.4.2013) EK IV
119. DEGAM - Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin. Demenz DEGAM-Leitlinie Nr. 12. 2008; http://leitlinien.degam. de/uploads/media/LL-12-Langfassung-TJ-03-korr-01.pdf zuletzt aufgerufen am 10.4.2013 EK IV
120. Strawbridge W. J., Shema S. J., Balfour J. L. et al. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci: 1998; 53 01 S9 S16 EK III
121. Kessler J., Calabrese P., Kalbe E. et al. DemTect. Ein neues Screening-Verfahren zur Unterstützung der Demenzdiagnostik. Psycho: 2000; 26 06 343 347
122. Kessler J., Markowitsch H. J., Denzler P. Mini-Mental-Status-Test (MMST). Göttingen Beltz: 2000
123. Shulman K. I., Pushkar Gold D., Cohen C. A. et al. Clock-drawing and dementia in the community: A longitudinal study. Int J Geriat Psychiatry: 1993; 8 06 487 496
124. Ihl R., Grass-Kapanke B. Test zur Früherkennung von Demenzen mit Depressionsabgrenzung (TFDD). Eigenverlag: 2000
125. Reisberg B., Finkel S., Overall J. et al. The Alzheimer's disease activities of daily living international scale (ADL-IS). Int Psychogeriatr: 2001; 13 02 163 181
126. Mahoney F., Barthel D. Functional evaluation: The Barthel Index. Md State Med J: 1965; 14 61 65
127. Lawton M. P., Brody E. M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist: 1969; 9 03 179 186
128. De Galan B. E., Zoungas S., Chalmers J. et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia: 2009; 52 11 2328 2336 EK Ib
129. Cukierman-Yaffe T., Gerstein H. C., Williamson J. D. et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diab Care: 2009; 32 02 221 226 EK Ib
130. Launer L. J., Miller M. E., Williamson J. D. et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol: 2011; 10 11 969 977 EK Ib
131. Ryan C. M., Freed M. I., Rood J. A. et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diab Care: 2006; 29 02 345 351 EK Ib
132. Hader C., Beischer W., Braun A. et al. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. Diabetes und Stoffwechsel: 2004; 13 02 S31 S56 EK IV
133. Zeyfang A., Bahrmann A., Wernecke J. Diabetes mellitus im Alter. Diabetologie und Stoffwechsel: 2012; 7 02 S163 S169 EK IV
134. Arbeitskreis FoDiAl. Fortbildung Diabetes in der Altenpflege - FoDiAl Curriculum für Altenpflegekräfte. Arbeitskreis FoDiAl (Hrsg.): 2006; http://www.fodial.de zuletzt aufgerufen am 16.4.2014. EK IV
135. Sinclair A. J., Woodhouse K. Meeting the challenge of diabetes in the aged. J R Soc Med: 1994; 87 10 607 EK IV
136. Seitz H. K., Bühringer G., Mann K. Grenzwerte für den Konsum alkoholischer Getränke. In: Deutsche Hauptstelle für Suchtfragen (Hrsg.) Jahrbuch Sucht. Geesthacht Neuland Verlagsgeselschaft: 2008; p. 205 210 EK IV
137. World Health Organization Global Status Report on Alcohol and Health. Geneva, Switzerland WHO Press: 2011; EK IV
138. Spangler J. G., Konen J. C., McGann K. P. Prevalence and predictors of problem drinking among primary care diabetic patients. J Fam Pract: 1993; 37 04 370 375 EK III
139. Kruse J., Schmitz N., Thefeld W. On the association between diabetes and mental disorders in a community sample: results from the German National Health Interview and Examination Survey. Diab Care: 2003; 26 06 1841 1846 EK III
140. Jacobson A. M., Hauser S. T., Willett J. B. et al. Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diab Care: 1997; 20 05 811 818 EK IIb
141. Pabst A., Piontek D., Kraus L. et al. Substanzkonsum und substanzbezogene Störungen. Sucht: 2010; 56 05 327 336 EK III
142. Jacobi F., Wittchen H. U., Holting C. et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med: 2004; 34 04 597 611 EK IIb
143. Carlsson S., Hammar N., Grill V. Alcohol consumption and type 2 diabetes - Meta-analysis of epidemiological studies indicates a U-shaped relationship. Diabetologia: 2005; 48 06 1051 1054 EK IIb
144. Koppes L. L., Dekker J. M., Hendriks H. F. et al. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diab Care: 2005; 28 03 719 725 EK IIb
145. Baliunas D. O., Taylor B. J., Irving H. et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diab Care: 2009; 32 11 2123 2132 EK IIb
146. Djousse L., Biggs M. L., Mukamal K. J. et al. Alcohol consumption and type 2 diabetes among older adults: the Cardiovascular Health Study. Obesity: 2007; 15 07 1758 1765 EK IIb
147. Djousse L., Arnett D. K., Eckfeldt J. H. et al. Alcohol consumption and metabolic syndrome: does the type of beverage matter? Obes Res: 2004; 12 09 1375 1385 EK IIb
148. Freiberg M. S., Cabral H. J., Heeren T. C. et al. Alcohol consumption and the prevalence of the Metabolic Syndrome in the U.S.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diab Care: 2004; 27 12 2954 2959 EK IIb
149. Yoon Y. S., Oh S. W., Baik H. W. et al. Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr: 2004; 80 01 217 224 EK IIb
150. AlKerwi A., Boutsen M., Vaillant M. et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis: 2009; 204 02 624 635 EK IIb
151. Hamaguchi M., Kojima T., Ohbora A. et al. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol: 2012; 18 02 156 167 EK III
152. Baik I., Shin C. Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr: 2008; 87 05 1455 1463 EK IIb
153. Buja A., Scafato E., Sergi G. et al. Alcohol consumption and metabolic syndrome in the elderly: results from the Italian longitudinal study on aging. Eur J Clin Nutr: 2010; 64 03 297 307 EK IIb
154. Hodge A. M., English D. R., O'Dea K. et al. Alcohol intake, consumption pattern and beverage type, and the risk of Type 2 diabetes. Diabet Med: 2006; 23 06 690 697 EK IIb
155. Jordan H. T., Tabaei B. P., Nash D. et al. Metabolic syndrome among adults in New York City. 2004 New York City Health and Nutrition Examination Servey. Prev Chronic Dis: 2012; 9 100260 EK IIb
156. Davies M. J., Baer D. J., Judd J. T. et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA: 2002; 287 19 2559 2562 EK Ib
157. Joosten M. M., Beulens J. W., Kersten S. et al. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia: 2008; 51 08 1375 1381 EK Ib
158. Bell R. A., Mayer-Davis E. J., Martin M. A. et al. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diab Care: 2000; 23 11 1630 1636 EK III
159. Magis D. C., Jandrain B. J., Scheen A. J. Alcohol, insulin sensitivity and diabetes. Rev Med Liege: 2003; 58 07 501 507 EK III
160. Kiechl S., Willeit J., Poewe W. et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ: 1996; 313 7064 1040 1044 EK IIb
161. Yokoyama H. Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a remedy for metabolic syndrome. Int J Environ Res Public Health: 2011; 8 07 3019 3031 EK III
162. Wakabayashi I. Associations between alcohol drinking and multiple risk factors for atherosclerosis in smokers and nonsmokers. Angiology: 2010; 61 05 495 503 EK III
163. Wakabayashi I. Impact of body weight on the relationship between alcohol intake and blood pressure. Alcohol Alcohol: 2009; 44 02 204 210 EK III
164. Balakrishnan V., Unnikrishnan A. G., Thomas V. et al. Chronic pancreatitis. A prospective nationwide study of 1,086 subjects from India. JOP: 2008; 9 05 593 600 EK III
165. Choudhuri G., Lakshmi C. P., Goel A. Pancreatic diabetes. Trop Gastroenterol: 2009; 30 02 71 75 EK III
166. Brand-Miller J. C., Fatema K., Middlemiss C. et al. Effect of alcoholic beverages on postprandial glycemia and insulinemia in lean, young, healthy adults. Am J Clin Nutr: 2007; 85 06 1545 1551 EK IIa
167. Ahmed A. T., Karter A. J., Warton E. M. et al. The relationship between alcohol consumption and glycemic control among patients with diabetes: the Kaiser Permanente Northern California Diabetes Registry. J Gen Intern Med: 2008; 23 03 275 282 EK IIb
168. Bantle A. E., Thomas W., Bantle J. P. Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism: 2008; 57 02 241 245 EK Ib
169. Avogaro A., Beltramello P., Gnudi L. et al. Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids. Diabetes: 1993; 42 11 1626 1634 EK IIa
170. Turner B. C., Jenkins E., Kerr D. et al. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diab Care: 2001; 24 11 1888 1893 EK IIa
171. Richardson T., Weiss M., Thomas P. et al. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diab Care: 2005; 28 07 1801 1802 EK Ib
172. Pedersen-Bjergaard U., Reubsaet J. L., Nielsen S. L. et al. Psychoactive drugs, alcohol, and severe hypoglycemia in insulin-treated diabetes: analysis of 141 cases. Am J Med: 2005; 118 03 307 310 EK III
173. Strachan M. WJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. In: Frier B. M., Fisher M. (eds.) Hypoglycaemia in Clinical Diabetes. 2 ed Chichester John Wiley & Sons: 2007; 49 81 EK III
174. Richardson T., Kerr D. Moderators, monitoring and management of hypoglycaemia. In: Frier B. M., Fisher M. (eds.). Hypoglycaemia in Clinical Diabetes. 2 ed Chichester John Wiley & Sons: 2007; 101 120 EK IIb
175. Fravel M. A., McDanel D. L., Ross M. B. et al. Special considerations for treatment of type 2 diabetes mellitus in the elderly. Am J Health Syst Pharm: 2011; 68 06 500 509 EK III
176. Gadsby R., Galloway M., Barker P. et al. Prescribed medicines for elderly frail people with diabetes resident in nursing homes-issues of polypharmacy and medication costs. Diabet Med: 2012; 29 01 136 139 EK III
177. Ahmed A. T., Karter A. J., Liu J. Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours. Diabet Med: 2006; 23 07 795 802 EK IIb
178. Karter A. J., Ferrara A., Darbinian J. A. et al. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diab Care: 2000; 23 04 477 483 EK IIb
179. Chew L. D., Nelson K. M., Young B. A. et al. Association between alcohol consumption and diabetes preventive practices. Fam Med: 2005; 37 08 589 594 EK IIb
180. Altenburg N., Joraschky P., Barthel A. et al. Alcohol consumption and other psycho-social conditions as important factors in the development of diabetic foot ulcers. Diabet Med: 2011; 28 02 168 174 EK III
181. World Health Organization Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland WHO Press: 2011; EK III
182. Danaei G., Ding E. L., Mozaffarian D. et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med: 2009; 6 04 e1000058 EK IIb
183. Borch-Johnsen K., Helweg-Larsen K. Sudden death and human insulin: is there a link? Diabet Med: 1993; 10 03 255 259 EK III
184. Ronksley P. E., Brien S. E., Turner B. J. et al. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ: 2011; 342 d671 EK IIb
185. Djousse L., Lee I. M., Buring J. E. et al. Alcohol consumption and risk of cardiovascular disease and death in women: potential mediating mechanisms. Circulation: 2009; 120 03 237 244 EK IIb
186. Hillbom M., Saloheimo P., Juvela S. Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep: 2011; 13 03 208 213 EK III
187. Targher G. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin Chem Lab Med: 2010; 48 02 147 157 EK IIb
188. Sluik D., Beulens J. W., Weikert C. et al. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus. Diabetes Metab Res Rev: 2012; 28 03 284 288 EK IIb
189. Beulens J. W., Kruidhof J. S., Grobbee D. E. et al. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study. Diabetologia: 2008; 51 09 1631 1638 EK IIb
190. Feuerlein W., Küfner H., Ringer C., Antons-Volmerg K. MALT: Münchener Alkoholismus Test. Göttingen Hogrefe: 1999
191. Funke W., Funke J., Klein M., Scheller R. Trierer Alkoholismusinventar (TAI). Göttingen Hogrefe: 1987
192. Rumpf H. J., Hapke U., John U. Deutsche Version des CAGE Fragebogens (CAGE-G). In: Glöckner-Rist A., Rist F., Küfner H. (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim Zentrum für Umfragen, Methoden und Analysen: 2003
193. Rumpf H. J., Hapke U., John U. Der Lübecker Alkoholabhä ngigkeits- und -missbrauchs-Screening-Test (LAST). In: Glöckner-Rist A., Rist F., Küfner H. (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim Zentrum für Umfragen, Methoden und Analysen: 2003
194. Rumpf H. J., Meyer C., Hapke U. et al. Deutsche Version des Alcohol Use Disorders Identification Test (AUDIT-G-L). In: Glöckner-Rist A., Rist F., Küfner H. (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim Zentrum für Umfragen, Methoden und Analysen: 2003
195. Rist F., Scheuren B., Demmel R. et al. Der Münsteraner Alcohol Use Disorders Identification Test (AUDIT-G-M). In: Glöckner-Rist A., Rist F., Küfner H. (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim Zentrum für Umfragen, Methoden und Analysen: 2003
196. Bischof G., Reinhardt S., Grothues J. et al. Development and evaluation of a screening instrument for alcohol-use disorders and at-risk drinking: the brief alcohol screening instrument for medical care (BASIC). J Stud Alcohol Drugs: 2007; 68 04 607 614
197. Schneider S., Margraf J. Diagnostisches Interview bei psyschischen Störungen (DIPS). 4. überarbeitete Aufl Berlin Springer: 2011
198. Wittchen H-U, Pfister H. DIA-X-Interview. Frankfurt Swets & Zeitlinger: 1997
199. Wittchen H-U, Lachner G., Perkonigg A. et al. Muenchner Composite International Diagnostic Interview (M-CIDI). Frankfurt Swets & Zeitlinger: 1996
200. Wittchen H-U, Zaudig M., Fydrich T. SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Handanweisung. Göttingen Hogrefe: 1997
201. Schippers G. M., Broekman T. G., Buchholz A. MATE-de 2.1. Handbuch und Leitfaden. Deutsche Bearbeitung: A. Buchholz, H. Küfner, L. Kraus, & F. Rist: 2011
202. Rist F., Demmel R., Hapke U. et al. Riskanter schädlicher und abhängiger Alkoholkonsum: Screening, Diagnostik, Kurzintervention. Leitlinien der AWMF. Sucht: 2004; 50 02 102 112 EK IV
203. Jepson R. G., Harris F. M., Platt S. et al. The effectiveness of interventions to change six health behaviours: a review of reviews. BMC Public Health: 2010; 10 538 EK IV
204. Whitlock E. P., Green C. A., Polen M. R. et al. Behavioral Counseling Interventions in Primary Care to Reduce Risky/Harmful Alcohol Use. 2004; http://www.ncbi.nlm.nih.gov/books/NBK42863/ [On-line]. PM:20722127. zuletzt aufgerufen am 10.5.2013. EK Ib
205. Bertholet N., Daeppen J. B., Wietlisbach V. et al. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med: 2005; 165 09 986 995 EK Ia
206. Cuijpers P., Riper H., Lemmers L. The effects on mortality of brief interventions for problem drinking: a meta-analysis. Addiction: 2004; 99 07 839 845 EK Ia
207. Kaner E. F., Beyer F., Dickinson H. O. et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev: 2007; 2 CD004148 EK Ia
208. Fleming M., Brown R., Brown D. The efficacy of a brief alcohol intervention combined with %CDT feedback in patients being treated for type 2 diabetes and/or hypertension. J Stud Alcohol: 2004; 65 05 631 637 EK Ib
209. Engler P. A., Ramsey S. E., Stein M. D. Brief alcohol intervention among diabetic patients: a pilot study. Presented at: Annual Meeting of the Society for Behavioral Medicine; March 26-29, 2008; San Diego, CA. 2008. EK IIa
210. Ramsey S. E., Engler P. A., Harrington M. et al. Brief Alcohol Intervention Among At-Risk Drinkers with Diabetes. Subst Abuse: 2010; 4 1 8 EK IIa
211. Saitz R. Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking. Drug Alcohol Rev: 2010; 29 06 631 640 EK Ia
212. Anderson P., Chisholm D., Fuhr D. C. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet: 2009; 373 9682 2234 2246 EK IV
213. Room R., Babor T., Rehm J. Alcohol and public health. Lancet: 2005; 365 9458 519 530 EK IV
214. Mundle G., Banger M., Mugele B. et al. AWMF-Behandlungsleitlinie: Akutbehandlung alkoholbezogener Störungen. Sucht: 2003; 49 03 147 167 EK IV
215. Schmidt L. G., Gastpar M., Falkai P. et al. Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogene Störungen. Köln Deutscher Ärzte-Verlag: 2006; EK IV
216. Pabst A., Piontek D., Kraus L. et al. Substanzkonsum und substanzbezogene Störungen. Sucht: 2010; 56 05 327 336 EK IIb
217. Hayes D. K., Fan A. Z., Smith R. A. et al. Trends in selected chronic conditions and behavioral risk factors among women of reproductive age, behavioral risk factor surveillance system, 2001-2009. Prev Chronic Dis: 2011; 8 06 A120 EK IIb
218. Kraus L., Pabst A., Piontek D. et al. Trends des Substanzkonsums und substanzbezogener Störungen. Sucht: 2010; 56 05 337 347 EK IIb
219. Altenhofen L., Brenner G., Hagen B. et al. Qualitä tssicherungsbericht 2005. Disease-Management-Programme in Nordrhein. Düsseldorf EK IIb: 2006
220. Hagen B., Altenhofen L., Blaschy S. et al. Qualitä tssicherungsbericht 2009. Disease-Management-Programme in Nordrhein. Düsseldorf EK IIb: 2010
221. Nakanishi N., Nakamura K., Matsuo Y. et al. Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men. Ann Intern Med: 2000; 133 03 183 191 EK IIb
222. Houston T. K., Person S. D., Pletcher M. J. et al. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ: 2006; 332 7549 1064 1069 EK IIb
223. Rafalson L., Donahue R. P., Dmochowski J. et al. Cigarette smoking is associated with conversion from normoglycemia to impaired fasting glucose: the Western New York Health Study. Ann Epidemiol: 2009; 19 06 365 371 EK IIb
224. Willi C., Bodenmann P., Ghali W. A. et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA: 2007; 298 22 2654 2664 EK Ia
225. Sairenchi T., Iso H., Nishimura A. et al. Cigarette smoking and risk of type 2 diabetes mellitus among middle-aged and elderly Japanese men and women. Am J Epidemiol: 2004; 160 02 158 162 EK IIb
226. Lyssenko V., Jonsson A., Almgren P. et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. NEJM: 2008; 359 21 2220 2232 EK IIb
227. Jee S. H., Foong A. W., Hur N. W. et al. Smoking and risk for diabetes incidence and mortality in Korean men and women. Diab Care: 2010; 33 12 2567 2572 EK IIb
228. Ley S. H., Hegele R. A., Harris S. B. et al. HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: a population-based epidemiological study. BMC Med Genet: 2011; 12 1 EK IIb
229. Liu T., Chen W. Q., David S. P. et al. Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. Eur J Endocrinol: 2011; 165 06 961 967 EK IIb
230. Morgan T. M., Crawford L., Stoller A. et al. Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers. Metabolism: 2004; 53 05 578 582 EK Ib
231. Nilsson P. M., Gudbjornsdottir S., Eliasson B. et al. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes - data from the National Diabetes Register in Sweden. Diabetes Metab: 2004; 30 03 261 268 EK IIb
232. Sargeant L. A., Khaw K. T., Bingham S. et al. Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol: 2001; 30 03 547 554 EK III
233. Morrish N. J., Stevens L. K., Fuller J. H. et al. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia: 1991; 34 08 590 594 EK IIb
234. Al-Delaimy W. K., Manson J. E., Solomon C. G. et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med: 2002; 162 03 273 279 EK IIb
235. Cederholm J., Eeg-Olofsson K., Eliasson B. et al. Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diab Care: 2008; 31 10 2038 2043 EK IIb
236. Nilsson P. M., Cederholm J., Eeg-Olofsson K. et al. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register. Eur J Cardiovasc Prev Rehabil: 2009; 16 04 506 512 EK IIb
237. Kothari V., Stevens R. J., Adler A. I. et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke: 2002; 33 07 1776 1781 EK IIb
238. Kengne A. P., Nakamura K., Barzi F. et al. Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region. J Diabetes: 2009; 1 03 173 181 EK IIb
239. Ford E. S., De Stefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Am J Epidemiol: 1991; 133 12 1220 1230 EK IIb
240. Al-Delaimy W. K., Willett W. C., Manson J. E. et al. Smoking and mortality among women with type 2 diabetes: The Nurses' Health Study cohort. Diab Care: 2001; 24 12 2043 2048 EK IIb
241. Fuller J. H., Stevens L. K., Wang S. L. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia: 2001; 44 02 S54 S64 EK IIb
242. De Stefano F., Ford E. S., Newman J. et al. Risk factors for coronary heart disease mortality among persons with diabetes. Ann Epidemiol: 1993; 3 01 27 34 EK IIb
243. Tan A. U., Hoffman B., Rosas S. E. Patient perception of risk factors associated with chronic kidney disease morbidity and mortality. Ethn Dis: 2010; 20 02 106 110 EK III
244. Retnakaran R., Cull C. A., Thorne K. I. et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes: 2006; 55 06 1832 1839 EK IIb
245. Ritz E., Orth S. R. Adverse effect of smoking on the renal outcome of patients with primary hypertension. Am J Kidney Dis: 2000; 35 04 767 769 EK III
246. Ritz E., Ogata H., Orth S. R. Smoking: a factor promoting onset and progression of diabetic nephropathy. Diabetes Metab: 2000; 26 04 54 63 EK III
247. Chuahirun T., Simoni J., Hudson C. et al. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci: 2004; 327 02 57 67 EK IIa
248. Chuahirun T., Wesson D. E. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition. Am J Kidney Dis: 2002; 39 02 376 382 EK IIb
249. Chuahirun T., Khanna A., Kimball K. et al. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis: 2003; 41 01 13 21 EK IIb
250. Rossing K., Christensen P. K., Hovind P. et al. Progression of nephropathy in type 2 diabetic patients. Kidney Int: 2004; 66 04 1596 1605 EK IIb
251. Orth S. R., Schroeder T., Ritz E. et al. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant: 2005; 20 11 2414 2419 EK IIb
252. Phisitkul K., Hegazy K., Chuahirun T. et al. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci: 2008; 335 04 284 291 EK III
253. Yokoyama H., Sone H., Oishi M. et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant: 2009; 24 04 1212 1219 EK III
254. Chaturvedi N., Stephenson J. M., Fuller J. H. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diab Care: 1995; 18 06 785 792 EK IIb
255. Roy M. S., Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol: 2006; 124 09 1297 1306 EK Ib
256. Stratton I. M., Kohner E. M., Aldington S. J. et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia: 2001; 44 02 156 163 EK IIb
257. Tesfaye S., Chaturvedi N., Eaton S. E. et al. Vascular risk factors and diabetic neuropathy. NEJM: 2005; 352 04 341 350 EK IIb
258. Tamer A., Yildiz S., Yildiz N. et al. The prevalence of neuropathy and relationship with risk factors in diabetic patients: a single-center experience. Med Princ Pract: 2006; 15 03 190 194 EK III
259. Will J. C., Galuska D. A., Ford E. S. et al. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol: 2001; 30 03 540 546 EK IIb
260. Hur N. W., Kim H. C., Nam C. M. et al. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil: 2007; 14 02 244 249 EK IIb
261. Voulgari C., Katsilambros N., Tentolouris N. Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study. Metabolism: 2011; 60 10 1456 1464 EK IIb
262. Eliasson B., Attvall S., Taskinen M. R. et al. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest: 1997; 27 05 450 456 EK IIb
263. Mikhailidis D. P., Papadakis J. A., Ganotakis E. S. Smoking, diabetes and hyperlipidaemia. J R Soc Health: 1998; 118 02 91 93 EK IIb
264. Iino K., Iwase M., Tsutsu N. et al. Smoking cessation and glycaemic control in type 2 diabetic patients. Diabetes Obes Metab: 2004; 6 03 181 186 EK IIa
265. Bodmer C. W., MacFarlane I. A., Flavell H. J. et al. How accurate is the smoking history in newly diagnosed diabetic patients? Diabetes Res Clin Pract: 1990; 10 03 215 220 EK III
266. Ardron M., MacFarlane I. A., Robinson C. et al. Anti-smoking advice for young diabetic smokers: is it a waste of breath? Diabet Med: 1988; 5 07 667 670 EK III
267. Wakefield M., Wilson D., Phillips P. et al. Smoking-related beliefs and behaviour of South Australians with diabetes. Aust J Public Health: 1995; 19 03 309 312 EK III
268. Schumann A., Rumpf H. J., Meyer C. et al. Deutsche Version des Fagerström-Test for Nicotine Dependence (FTND-G) und des Heaviness of Smoking Index (HSI-G). In: Glöckner-Rist A., Rist F., Küfner H. (Hrsg.). Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES). Version 3.00 Mannheim Zentrum für Umfragen, Methoden und Analysen: 2003
269. Mottillo S., Filion K. B., Belisle P. et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J: 2009; 30 06 718 730 EK Ia
270. Batra A., Schütz C. G., Lindinger P. Tabakabhängigkeit. In: Schmidt L. G., Gastpar M., Falkai P., Gaebel W. (Hrsg.) Evidenzbasierte Suchtmedizin. Behandlungsleitlinie Substanzbezogener Störungen. Köln Deutscher Ärzte-Verlag: 2006; 91 142 EK IV
271. Kröger B., Piontek D. Tabakentwöhnung in Deutschland. Grundlagen und kommentierte Übersicht. Gesundheitsförderung konkret. Band 2 Köln Bundeszentrale für gesundheitliche Aufklärung (BZgA) EK IV: 2011
272. Davies M. J., Heller S., Khunti K. et al. The DESMOND educational intervention. Chronic lllness: 2008; 01 38 40 EK Ib
273. Hokanson J. M., Anderson R. L., Hennrikus D. J. et al. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. Diabetes Educ: 2006; 32 04 562 570 EK Ib
274. Persson L. G., Hjalmarson A. Smoking cessation in patients with diabetes mellitus: results from a controlled study of an intervention programme in primary healthcare in Sweden. Scand J Prim Health Care: 2006; 24 02 75 80 EK IIa
275. Canga N., De Irala J., Vara E. et al. Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. Diab Care: 2000; 23 10 1455 1460 EK IIa
276. Eisenberg M. J., Filion K. B., Yavin D. et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ: 2008; 179 02 135 144 EK Ia
277. Stead L. F., Perera R., Bullen C. et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev: 2008; 1 CD000146 EK Ia
278. Andreas S., Batra A., Behr J. et al. Tabakentwöhnung bei COPD - S3 Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie: 2008; 62 05 255 272 EK IV
279. Fiore M. C., Jaén C. R., Baker T. B. et al. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med: 2008; 35 02 158 176 EK IV
280. Parsons A. C., Shraim M., Inglis J. et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev: 2009; 1 CD006219 EK Ia
281. Häfner H., Maurer K., Ruhrmann S. et al. Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci: 2004; 254 02 117 128 EK IV
282. Gaebel W., Falkai P. S3-Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1 Behandlungsleitlinie Schizophrenie. Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (Hrsg.). Darmstadt Steinkopff-Verlag: 2006; EK IV
283. Myers K. A., Edwards A. L. Diabetic patients with psychiatric illness. Curr Diabetes Rev: 2010; 6 04 222 227 EK IV
284. Osborn D. P., Wright C. A., Levy G. et al. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry: 2008; 8 84 EK Ia
285. Reist C., Mintz J., Albers L. J. et al. Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002. J Clin Psychopharmacol: 2007; 27 01 46 51 EK III
286. Cavazzoni P., Mukhopadhyay N., Carlson C. et al. Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications. Br J Psychiatry: 2004; 47 S94 S101 EK III
287. Ryan M. C., Collins P., Thakore J. H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry: 2003; 160 02 284 289 EK III
288. Hennekens C. H. Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. J Clin Psychiatry: 2007; 68 04 4 7 EK IV
289. ADA APA AACE et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry: 2004; 65 02 267 272 EK IV
290. Woo V., Harris S. B., Houlden R. N. Canadian Diabetes Association Position Paper: Antipsychotic medications and associated risks of weight gain and diabetes. Can J Diabetes: 2005; 29 02 111 112 EK IV
291. Jennex A., Gardner D. M. Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study. Can J Psychiatry: 2008; 53 01 34 42 EK III
292. Morrato E. H., Newcomer J. W., Kamat S. et al. Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes. Diab Care: 2009; 32 06 1037 1042 EK III
293. Simon V., van Winkel R., de Hert M. Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. J Clin Psychiatry: 2009; 70 07 1041 1050 EK IV
294. Allison D. B., Mentore J. L., Heo M. et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry: 1999; 156 11 1686 1696 EK IIa
295. Kahn R. S., Fleischhacker W. W., Boter H. et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet: 2008; 371 9618 1085 1097 EK Ib
296. Lieberman J. A. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. J Clin Psychiatry: 2007; 68 02 e04 EK Ib
297. Jin H., Meyer J. M., Jeste D. V. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res: 2004; 71 02 195 212 EK IV
298. Henderson D. C., Cagliero E., Copeland P. M. et al. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. J Clin Psychiatry: 2007; 68 04 533 541 EK III
299. Tiihonen J., Lönnqvist J., Wahlbeck K. et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet: 2009; 374 9690 620 627 EK III
300. Böhm B. O., Dreyer M., Fritsche A. et al. Therapie des Diabetes mellitus Typ 1. S3-Leitlinie herausgegeben von der Deutschen Diabetes-Gesellschaft. (http://www.deutsche-diabetes-gesellschaft.de/fileadmin/ Redakteur/Leitlinien/Evidenzbasierte-Leitlinien/ AktualisierungTherapieTyp1Diabetes-1-20120319-TL.pdf; zuletzt aufgerufen am 10.4.2013) EK IV
301. Matthaei S., Bierwirth R., Fritsche A. et al. Medikamentöse antihyperglykämische Therapie des Diabetes mellitus Typ 2. Update der Evidenzbasierten Leitlinie der Deutschen Diabetes-Gesellschaft. Diabetologie und Stoffwechsel: 2009; 4 01 32 64 EK IV
302. Mauri M., Simoncini M., Castrogiovanni S. et al. A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry: 2008; 41 01 17 23 EK Ib
303. Weber M., Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res: 2006; 83 01 95 101 EK Ib
304. McKibbin C. L., Patterson T. L., Norman G. et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res: 2006; 86 01 36 44 EK Ib
305. McKibbin C. L., Golshan S., Griver K. et al. A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis. Schizophr Res: 2010; 121 01 203 206 EK Ib
306. Ehret M., Goethe J., Lanosa M. et al. The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. J Clin Psychiatry: 2010; 71 10 1286 1292 EK Ia
307. Anderson R. J., Freedland K. E., Clouse R. E. et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diab Care: 2001; 24 06 1069 1078 EK III
308. Huang C. Q., Dong B. R., Lu Z. C. et al. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev: 2010; 9 02 131 141 EK Ib
309. Ali S., Stone M. A., Peters J. L. et al. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med: 2006; 23 11 1165 1173 EK Ia
310. Barnard K. D., Skinner T. C., Peveler R. The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med: 2006; 23 04 445 448 EK Ia
311. Mezuk B., Eaton W. W., Albrecht S. et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diab Care: 2008; 31 12 2383 2390 EK Ia
312. Chang-Quan H., Xue-Mei Z., Bi-Rong D. et al. Health status and risk for depression among the elderly: a meta-analysis of published literature. Age Ageing: 2010; 39 01 23 30 EK III
313. Icks A., Kruse J., Dragano N. et al. Are symptoms of depression more common in diabetes? Results from the Heinz Nixdorf Recall study. Diabet Med: 2008; 25 11 1330 1336 EK III
314. Petrak F., Hardt J., Wittchen H. U. et al. Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes. Diabetes Metab Res Rev: 2003; 19 03 216 222 EK III
315. Hermanns N., Kulzer B., Krichbaum M. et al. Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med: 2005; 22 03 293 300 EK III
316. Knol M. J., Twisk J. W., Beekman A. T. et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia: 2006; 49 05 837 845 EK Ia
317. Cosgrove M. P., Sargeant L. A., Griffin S. J. Does depression increase the risk of developing type 2 diabetes? Occup Med: 2008; 58 01 7 14 EK Ia
318. Nouwen A., Winkley K., Twisk J. et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia: 2010; 53 12 2480 2486 EK Ia
319. De Groot M., Anderson R., Freedland K. E. et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med: 2001; 63 04 619 630 EK III
320. Pouwer F., Beekman A. T., Nijpels G. et al. Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study. Diabetologia: 2003; 46 07 892 898 EK III
321. Peyrot M., Rubin R. R. Persistence of depressive symptoms in diabetic adults. Diab Care: 1999; 22 03 448 452 EK III
322. Goldney R. D., Phillips P. J., Fisher L. J. et al. Diabetes, depression, and quality of life: a population study. Diab Care: 2004; 27 05 1066 1070 EK III
323. Schram M. T., Baan C. A., Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev: 2009; 5 02 112 119 EK III
324. Ali S., Stone M., Skinner T. C. et al. The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev: 2010; 26 02 75 89 EK Ia
325. Egede L. E. Diabetes, Major Depression, and Functional Disability among U.S. Adults. Diab Care: 2004; 27 02 421 428 EK III
326. Gregg E. W., Mangione C. M., Cauley J. A. et al. Diabetes and incidence of functional disability in older women. Diab Care: 2002; 25 01 61 67 EK III
327. Bruce D. G., Davis W. A., Starkstein S. E. et al. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia: 2005; 48 12 2532 2539 EK III
328. Ciechanowski P. S., Katon W. J., Russo J. E. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med: 2000; 160 21 3278 3285 EK III
329. Egede L. E., Zheng D., Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diab Care: 2002; 25 03 464 470 EK III
330. Simon G. E., Katon W. J., Lin E. H. et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry: 2005; 27 05 344 351 EK III
331. Black S. A., Markides K. S., Ray L. A. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diab Care: 2003; 26 10 2822 2828 EK III
332. Katon W. J., Von Korff M., Lin E. H. et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry: 2004; 61 10 1042 1049 EK Ib
333. Zhang X., Norris S. L., Gregg E. W. et al. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol: 2005; 161 07 652 660 EK III
334. Katon W., Fan M. Y., Unutzer J. et al. Depression and diabetes: a potentially lethal combination. J Gen Intern Med: 2008; 23 10 1571 1575 EK III
335. Richardson L. K., Egede L. E., Mueller M. et al. Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. Gen Hosp Psychiatry: 2008; 30 06 509 514 EK III
336. Young B. A., Von Korff M., Heckbert S. R. et al. Association of major depression and mortality in Stage 5 diabetic chronic kidney disease. Gen Hosp Psychiatry: 2010; 32 02 119 124 EK III
337. Lustman P. J., Anderson R. J., Freedland K. E. et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diab Care: 2000; 23 07 934 942 EK III
338. Pouwer F., Snoek F. J. Association between symptoms of depression and
339. Gonzalez J. S., Peyrot M., McCarl L. A. et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diab Care: 2008; 31 12 2398 2403 EK IIb
340. Gonzalez J. S., Safren S. A., Delahanty L. M. et al. Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med: 2008; 25 09 1102 1107 EK III
341. Marcus M. D., Wing R. R., Guare J. et al. Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients. Diab Care: 1992; 15 02 253 255 EK III
342. Rubin R. R., Gaussoin S. A., Peyrot M. et al. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia: 2010; 53 08 1581 1589 EK III
343. Wolkowitz O. M., Reus V. I., Mellon S. H. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci: 2011; 13 01 25 39 EK III
344. Stuart M. J., Baune B. T. Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev: 2012; 36 01 658 676 EK III
345. Hermanns N., Kulzer B., Krichbaum M. et al. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia: 2006; 49 03 469 477 EK III
346. Pouwer F., Beekman A. T., Lubach C. et al. Nurses' recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus. Patient Educ Couns: 2006; 60 02 235 240 EK III
347. Rubin R. R., Ciechanowski P., Egede L. E. et al. Recognizing and treating depression in patients with diabetes. Current Diabetes Reports: 2004; 4 02 119 125 EK IV
348. Whooley M. A., Avins A. L., Miranda J. et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med: 1997; 12 07 439 445 EK III
349. Arroll B., Khin N., Kerse N. Screening for depression in primary care with two verbally asked questions: cross sectional study. BMJ: 2003; 327 7424 1144 1146 EK III
350. Arroll B., Goodyear-Smith F., Kerse N. et al. Effect of the addition of a "helpo" question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ: 2005; 331 884 EK III
351. Hautzinger M., Bailer J., Hofmeister D. et al. ADS. Allgemeine Depressions-Skala. 2. Aufl Göttingen Hogrefe: 2012
352. Hautzinger M., Keller F., Kühner C. Beck Depressions-Inventar (BDI-II). Revision. Frankfurt/Main Harcourt Test Services: 2006
353. Herrmann-Lingen C., Buss U., Snaith R. P. HADS-D. Hospital Anxiety and Depression Scale - Deutsche Version. 3. aktualisierte Aufl Bern Huber: 2011
354. Gräfe K., Zipfel S., Herzog W. et al. Screening psychischer Störungen mit dem Gesundheitsfragebogen für Patienten (PHQ-D)". Ergebnisse der deutschen Validierungsstudie. Diagnostica: 2004; 50 04 171 181
355. Roy T., Lloyd C. E., Pouwer F. et al. Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabet Med: 2012; 29 02 164 175 EK III
356. DGPPN, BÄK, KBV, AWMF et al. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression - Langfassung. 2012; http://www.versorgungsleitlinien.de/themen/depression/pdf/s3-nvl-depression- lang.pdf zuletzt aufgerufen am 10.4.2013. EK IV
357. Fisher L., Skaff M. M., Mullan J. T. et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med: 2008; 25 09 1096 1101 EK III
358. Fisher L., Glasgow R. E., Strycker L. A. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diab Care: 2010; 33 05 1034 1036 EK III
359. Harris E. C., Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry: 1997; 170 205 228 EK III
360. Harris E. C., Barraclough B. Excess mortality of mental disorder. Br J Psychiatry: 1998; 173 11 53 EK III
361. Brieger P., Marneros A. Komorbidität bei psychiatrischen Krankheiten Einige theoretische Überlegungen. Nervenarzt: 2000; 71 07 525 534 EK IV
362. Pouwer F. Should we screen for emotional distress in type 2 diabetes mellitus? Nat Rev Endocrinol: 2009; 5 12 665 671 EK IV
363. Pouwer F., Tack C. J., Geelhoed-Duijvestijn P. H. et al. Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trial. Diabetologia: 2011; 54 04 741 748 EK Ib
364. van der Feltz-Cornelis C. M., Nuyen J., Stoop C. et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry: 2010; 32 04 380 395 EK Ia
365. van Bastelaar K. M., Pouwer F., Cuijpers P. et al. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diab Care: 2011; 34 02 320 325 EK Ib
366. Lustman P. J., Griffith L. S., Clouse R. E. et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med: 1997; 59 03 241 250 EK Ib
367. Goodnick P. J., Kumar A., Henry J. H. et al. Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol Bull 33 02 261 264 EK IIb
368. David S. [SSRI should be considered as the cause of hypoglycemias which are difficult to explain]. Lakartidningen: 2005; 102 08 582 EK IV
369. Derijks H. J., Heerdink E. R., De Koning F. H. et al. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemioloy and Drug Safety: 2008; 17 04 336 344 EK IV
370. Derijks H. J., Meyboom R. H., Heerdink E. R. et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol: 2008; 64 05 531 538 EK IV
371. Goldstein D. J., Lu Y., Detke M. J. et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain: 2005; 116 01 109 118 EK IV
372. Perahia D. G., Kajdasz D. K., Royer M. G. et al. Duloxetine in the treatment of major depressive disorder: an assessment of the relationship between outcomes and episode characteristics. Int Clin Psychopharmacol: 2006; 21 05 285 295 EK III
373. Perahia D. G., Pritchett Y. L., Desaiah D. et al. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect? Int Clin Psychopharmacol: 2006; 21 06 311 317 EK III
374. Kubiak T., Weik A., Kulzer B., Hermanns N. Behandlung psychischer Störungen bei Diabetes mellitus. In: Härter M., Baumeister H., Bengel J. (Hrsg.). Psychische Störungen bei körperlichen Erkrankungen. Springer Heidelberg: 2007; 111 123 EK III
375. Boulton A. J., Vinik A. I., Arezzo J. C. et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diab Care: 2005; 28 04 956 962 EK IV
376. Bogner H. R., de Vries H. F. Integrating type 2 diabetes mellitus and depression treatment among african americans: a randomized controlled pilot trial. Diabetes Educ: 2010; 36 02 284 292 EK Ib
377. Ell K., Katon W., Xie B. et al. Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial. Diab Care: 2010; 33 04 706 713 EK Ib
378. Ell K., Aranda M. P., Xie B. et al. Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials. Am J Geriatr Psychiatry: 2010; 18 06 520 530 EK Ib
379. Katon W. J., Lin E. H., Von Korff M. et al. Collaborative care for patients with depression and chronic illnesses. NEJM: 2010; 363 27 2611 2620 EK Ib
380. Williams J. W Jr, Katon W., Lin E. H. et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med: 2004; 140 12 1015 1024 EK Ib
381. Herring M. P., Puetz T. W., O'Connor P. J. et al. Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med: 2012; 172 02 101 111 EK Ia
382. Wittchen H. U., Muller N., Pfister H. et al. Affective, somatoform and anxiety disorders in Germany - initial results of an additional federal survey of "psychiatric disorderso" Gesundheitswesen: 1999; 61 S216 S222 EK III
383. Meyer C., Rumpf H. J., Hapke U. et al. Lebenszeitprävalenz psychischer Störungen in der erwachsenen Allgemeinbevölkerung Ergebnisse der TACOS-Studie. Nervenarzt: 2000; 71 07 535 542 EK III
384. Li C., Barker L., Ford E. S. et al. Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabet Med: 2008; 25 07 878 881 EK III
385. Lin E. H., Korff M. V., Alonso J. et al. Mental disorders among persons with diabetes - results from the World Mental Health Surveys. Journal of Psychosomatic Research: 2008; 65 06 571 580 EK III
386. Berlin I., Bisserbe J. C., Eiber R. et al. Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults. Diab Care: 1997; 20 02 176 178 EK III
387. Grigsby A. B., Anderson R. J., Freedland K. E. et al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res: 2002; 53 06 1053 1060 EK III
388. Collins M. M., Corcoran P., Perry I. J. Anxiety and depression symptoms in patients with diabetes. Diabet Med: 2009; 26 02 153 161 EK III
389. Lloyd C. E., Dyer P. H., Barnett A. H. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med: 2000; 17 03 198 202 EK III
390. Wu S. F., Huang Y. C., Liang S. Y. et al. Relationships among depression, anxiety, self-care behaviour and diabetes education difficulties in patients with type-2 diabetes: a cross-sectional questionnaire survey. Int J Nurs Stud: 2011; 48 11 1376 1383 EK III
391. Labad J., Price J. F., Strachan M. W. et al. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia: 2010; 53 03 467 471 EK III
392. Duran-Atzinger G. Alltagsbelastungen bei Patienten mit Diabetes mellitus. Regensburg: 1992; EK III
393. Snoek F. J., Pouwer F., Welch G. W. et al. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diab Care: 2000; 23 09 1305 1309 EK III
394. Welch G. W., Jacobson A. M., Polonsky W. H. The Problem Areas in Diabetes Scale. An evaluation of its clinical utility. Diab Care: 1997; 20 05 760 766 EK III
395. Mollema E. D., Snoek F. J., Ader H. J. et al. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res: 2001; 51 05 665 672 EK III
396. Petrak F., Stridde E., Leverkus F. et al. Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diab Care: 2007; 30 09 2199 2204 EK III
397. Snoek F. J., Mollema E. D., Heine R. J. et al. Development and validation of the diabetes fear of injecting and self-testing questionnaire (D-FISQ): first findings. Diabet Med: 1997; 14 10 871 876 EK III
398. Mollema E. D., Snoek F. J., Heine R. J. et al. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med: 2001; 18 08 671 674 EK III
399. Zambanini A., Newson R. B., Maisey M. et al. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract: 1999; 46 03 239 246 EK III
400. Peyrot M., Rubin R. R., Lauritzen T. et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diab Care: 2005; 28 11 2673 2679 EK III
401. Brod M., Kongso J. H., Lessard S. et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res: 2009; 18 01 23 32 EK IV
402. Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ: 2006; 32 01 9S 18S EK IV
403. Nam S., Chesla C., Stotts N. A. et al. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diab Care: 2010; 33 08 1747 1749 EK III
404. Petrak F. Psychologische Barrieren der Insulintherapie bei Patienten mit Typ-2-Diabetes. Diabetes, Stoffwechsel und Herz: 2006; 15 28 34 EK III
405. Petrak F., Joschko A., Kaltheuner M. et al. Psychische Belastungen und Therapieadhärenz von Patienten mit Diabetes in diabetologischen Schwerpunktpraxen. Diabetes, Stoffwechsel und Herz: 2011; 20 7 14 EK III
406. Hummel J., Kuhner C., Kopf D. et al. Psychosocial barriers to starting insulin therapy in type 2 diabetes mellitus. Diabetes Res Clin Pract: 2008; 82 03 e25 e26 EK III
407. Kohen D., Burgess A. P., Catalan J. et al. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Qual Life Res: 1998; 7 03 197 204 EK III
408. Fu A. Z., Qiu Y., Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin: 2009; 25 06 1413 1420 EK III
409. National Collaborating Centre for Mental Health (UK) Generalised Anxiety Disorder in Adults: Management in Primary, Secondary and Community Care. (NICE Clinical Guidelines, No. 113). Leicester British Psychological Society: 2011; EK IV
410. Kulzer B. Angst vor Unterzuckerungen. In: Kohlmann C. W., Kulzer B. (Hrsg.). Diabetes und Psychologie.: 1995; 64 80
411. Löwe B., Spitzer R. L., Zipfel S. et al. PHQ-D. Gesundheitsfragebogen für Patienten. Autorisierte deutsche Version des Prime MD Patient Health Questionnaire (PHQ)" 2. Aufl Karlsruhe Pfizer: 2002
412. Margrarf J. Diagnostisches Kurzinterview für psychische Störungen (Mini-DIPS). Berlin Springer: 1994
413. Dengler W., Selbmann H. Leitlinien zur Diagnostik und Therapie von Angsterkrankungen. Darmstadt Steinkopff: 2001; EK IV
414. Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry: 2009; 70 02 20 24 EK IV
415. Carter R. M., Wittchen H. U., Pfister H. et al. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety: 2001; 13 02 78 88 EK III
416. Kessler R. C., Chiu W. T., Demler O. et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry: 2005; 62 06 617 627 EK III
417. Bell D. S., Christian S. T., Clements R. S. et al. Acuphobia in a long-standing insulin-dependent diabetic patient cured by hypnosis. Diab Care: 1983; 6 06 622 EK IV
418. Kolko D. J., Milan M. A. Misconception correction through reading in the treatment of a self-injection phobia. J Behav Ther Exp Psychiatry: 1980; 11 04 273 276 EK IV
419. Steel J., Taylor R., Lloyd G. Behaviour therapy for phobia of venepuncture. Diabet Med: 1986; 3 05 481 EK IV
420. Zambanini A., Feher M. D. Needle phobia in type 1 diabetes mellitus. Diabet Med: 1997; 14 04 321 323 EK IV
421. Fröhlich C., Zettler A., Reinecker H. et al. Evaluation eines Gruppentrainings zur Verbesserung der Hypoglykämiewahrnehmung (WT) und Angstbewältigung (AT). Praxis der Klinischen Verhaltensmedizin und Rehabilitation: 1992; 17 05 30 34 EK IIa
422. Cox D. J., Gonder-Frederick L., Polonsky W. et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diab Care: 2001; 24 04 637 642 EK IIb
423. Zettler A., Duran G., Waadt S. et al. Coping with fear of long-term complications in diabetes mellitus: a model clinical program. Psychother Psychosom: 1995; 64 03 178 184 EK IIb
424. Sanchez-Meca J., Rosa-Alcazar A. I., Marin-Martinez F. et al. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin Psychol Rev: 2010; 30 01 37 50 EK Ia
425. Wolitzky-Taylor K. B., Horowitz J. D., Powers M. B. et al. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev: 2008; 28 06 1021 1037 EK Ia
426. Siev J., Chambless D. L. Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders. J Consult Clin Psychol: 2007; 75 04 513 522 EK Ia
427. Spek V., Cuijpers P., Nyklicek I. et al. Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med: 2007; 37 03 319 328 EK Ia
428. Furukawa T. A., Watanabe N., Churchill R. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. Br J Psychiatry: 2006; 188 305 312 EK Ia
429. Mitte K., Noack P., Steil R. et al. A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J Clin Psychopharmacol: 2005; 25 02 141 150 EK Ia
430. Bakker A., van Balkom A. J., Spinhoven P. SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand: 2002; 106 03 163 167 EK Ia
431. APA - American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. DSM-IV-TR (4th edition, Text Revision). American Psychiatric Association, Washington, DC; 2003. [deutsch: Saß H, Wittchen HU, Zaudig M (Hrsg.) Diagnostisches und Statistisches Manual Psychischer Störungen. DSM-IV-TR. (4. Aufl., Textrevision.) Göttingen Hogrefe: 2003
432. Stunkard A. J., GRACE W. J., Wolff H. G. The night-eating syndrome: A pattern of food intake among certain obese patients. The American Journal of Medicine: 1955; 19 01 78 86 EK IV
433. Mühlhans B., Olbrich K., de Zwaan M. Night Eating Syndrom und nächtliches Essen - was ist das eigentlich? Psychother Psychosom Med Psychol: 2009; 59 02 50 56 EK IV
434. DGPM, DKMP, DGKJP et al. S3-Leitlinie. Diagnostik und Therapie der Essstörungen. 2010; http://www.awmf.org/uploads/tx-szleitlinien/051-026l- S3-Diagnostik-Therapie-Essstörungen.pdf zuletzt aufgerufen am 18.12.2012. EK IV
435. O'Brien K. M., Vincent N. K. Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships. Clin Psychol Rev: 2003; 23 01 57 74 EK III
436. Bornstein R. F. A Meta-Analysis of the Dependency-Eating-Disorders Relationship: Strength, Specificity, and Temporal Stability. Journal of Psychopathology and Behavioral Assessment: 2001; 23 03 151 162 EK Ib
437. Cassin S. E., von Ranson K. M. Personality and eating disorders: a decade in review. Clin Psychol Rev: 2005; 25 07 895 916 EK III
438. Neumark-Sztainer D., Patterson J., Mellin A. et al. Weight control practices and disordered eating behaviors among adolescent females and males with type 1 diabetes: associations with sociodemographics, weight concerns, familial factors, and metabolic outcomes. Diab Care: 2002; 25 08 1289 1296 EK III
439. Helgeson V. S., Siminerio L., Escobar O. et al. Predictors of metabolic control among adolescents with diabetes: a 4-year longitudinal study. J Pediatr Psychol: 2009; 34 03 254 270 EK IIb
440. Grylli V., Hafferl-Gattermayer A., Schober E. et al. Prevalence and clinical manifestations of eating disorders in Austrian adolescents with type-1 diabetes. Wien Klin Wochenschr: 2004; 116 07 230 234 EK IIb
441. Engström I., Kroon M., Arvidsson C. G. et al. Eating disorders in adolescent girls with insulin-dependent diabetes mellitus: a population-based case-control study. Acta Paediatr: 1999; 88 02 175 180 EK IIa
442. Jones J. M., Lawson M. L., Daneman D. et al. Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. BMJ: 2000; 320 7249 1563 1566 EK IIa
443. Alice Hsu YY, Chen B. H., Huang M. C. et al. Disturbed eating behaviors in Taiwanese adolescents with type 1 diabetes mellitus: a comparative study. Pediatr Diabetes: 2009; 10 01 74 81 EK III
444. Colton P., Olmsted M., Daneman D. et al. Disturbed eating behavior and eating disorders in preteen and early teenage girls with type 1 diabetes: a case-controlled study. Diab Care: 2004; 27 07 1654 1659 EK III
445. Olmsted M. P., Daneman D., Rydall A. C. et al. The effects of psychoeducation on disturbed eating attitudes and behavior in young women with type 1 diabetes mellitus. Int J Eat Disord: 2002; 32 02 230 239 EK III
446. Fairburn C. G., Peveler R. C., Davies B. et al. Eating disorders in young adults with insulin dependent diabetes mellitus: a controlled study. BMJ: 1991; 303 6793 17 20 EK IIa
447. Peveler R. C., Fairburn C. G., Boller I. et al. Eating disorders in adolescents with IDDM. A controlled study. Diab Care: 1992; 15 10 1356 1360 EK IIa
448. Striegel-Moore R. H., Nicholson T. J., Tamborlane W. V. Prevalence of eating disorder symptoms in preadolescent and adolescent girls with IDDM. Diab Care: 1992; 15 10 1361 1368 EK IIa
449. Nielsen S., Molbak A. G. Eating disorder and type 1 diabetes: overview and summing-up. Eur Eat Disorders Rev: 1998; 6 01 4 26 EK Ia
450. Morse S. A., Ciechanowski P. S., Katon W. J. et al. Isn't this just bedtime snacking? The potential adverse effects of night-eating symptoms on treatment adherence and outcomes in patients with diabetes. Diab Care: 2006; 29 08 1800 1804 EK III
451. Mannucci E., Rotella F., Ricca V. et al. Eating disorders in patients with type 1 diabetes: a meta-analysis. J Endocrinol Invest: 2005; 28 05 417 419 EK Ib
452. Crow S., Kendall D., Praus B. et al. Binge eating and other psychopathology in patients with type II diabetes mellitus. Int J Eat Disord: 2001; 30 02 222 226 EK IIb
453. Papelbaum M., Appolinario J. C., Moreira R. O. et al. Prevalence of eating disorders and psychiatric comorbidity in a clinical sample of type 2 diabetes mellitus patients. Rev Bras Psiquiatr: 2005; 27 02 135 138 EK III
454. Kenardy J., Mensch M., Bowen K. et al. A comparison of eating behaviors in newly diagnosed NIDDM patients and case-matched control subjects. Diab Care: 1994; 17 10 1197 1199 EK IIa
455. Allison K. C., Crow S. J., Reeves R. R. et al. Binge eating disorder and night eating syndrome in adults with type 2 diabetes. Obesity (Silver Spring): 2007; 15 05 1287 1293 EK IIb
456. Gorin A. A., Niemeier H. M., Hogan P. et al. Binge eating and weight loss outcomes in overweight and obese individuals with type 2 diabetes: results from the Look AHEAD trial. Arch Gen Psychiatry: 2008; 65 12 1447 1455 EK IIb
457. Herpertz S., Albus C., Wagener R. et al. Comorbidity of diabetes and eating disorders. Does diabetes control reflect disturbed eating behavior? Diab Care: 1998; 21 07 1110 1116 EK III
458. Stancin T., Link D. L., Reuter J. M. Binge eating and purging in young women with IDDM. Diab Care: 1989; 12 09 601 603 EK III
459. Rydall A. C., Rodin G. M., Olmsted M. P. et al. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. NEJM: 1997; 336 26 1849 1854 EK IIa
460. Goebel-Fabbri A. E., Fikkan J., Connell A. et al. Identification and treatment of eating disorders in women with type 1 diabetes mellitus. Treat Endocrinol: 2002; 1 03 155 162 EK III
461. de Beaufort C. E., Swift P. G., Skinner C. T. et al. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diab Care: 2007; 30 09 2245 2250 EK III
462. Takii M., Uchigata Y., Tokunaga S. et al. The duration of severe insulin omission is the factor most closely associated with the microvascular complications of Type 1 diabetic females with clinical eating disorders. Int J Eat Disord: 2008; 41 03 259 264 EK IIb
463. Nielsen S., Emborg C., Molbak A. G. Mortality in concurrent type 1 diabetes and anorexia nervosa. Diab Care: 2002; 25 02 309 312 EK IIb
464. Herpertz S., Herpertz-Dahlmann B., Fichter M. et al. S3-Leitlinie. Diagnostik und Behandlung der Essstörungen. 1. Aufl Berlin Springer: 2011; EK IV
465. Bahrke U., Bandemer-Greulich U., Fikentscher E. et al. Erfassung essgestörten Verhaltens bei Patientinnen mit Diabetes mellitus mit Hilfe eines Fragebogens (Diab-Ess). Diabetologie und Stoffwechsel: 2006; 1 01 46 53
466. Feiereis H. Diabetes mellitus Typ I und Bulimie - eine bedrohliche Doppelkrankheit. Dtsch Med Wochenschr: 1988; 113 48 1876 1878 EK IV
467. Peveler R. C., Fairburn C. G. Anorexia nervosa in association with diabetes mellitus - a cognitive-behavioral approach to treatment. Behaviour Research and Therapy: 1989; 27 95 99 EK IV
468. Herpertz S., von Blume B., Senf W. Essstörungen und Diabetes mellitus. Z Psychosom Med Psychoanal: 1995; 41 04 329 343 EK IV
469. Takii M., Uchigata Y., Komaki G. et al. An integrated inpatient therapy for type 1 diabetic females with bulimia nervosa: a 3-year follow-up study. J Psychosom Res: 2003; 55 04 349 356 EK IIb
470. Daneman D., Rodin G., Jones J. et al. Eating Disorders in Adolescent Girls and Young Adult Women With Type 1 Diabetes. Diabetes Spectr: 2002; 15 02 83 105 EK IV
471. Kenardy J., Mensch M., Bowen K. et al. Group therapy for binge eating in Type 2 diabetes: a randomized trial. Diabet Med: 2002; 19 03 234 239 EK IIa
472. Osterberg L., Blaschke T. Adherence to medication. NEJM: 2005; 353 05 487 497 EK IV
473. Blaschke T. F., Osterberg L., Vrijens B. et al. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol: 2012; 52 275 301 EK IV
474. Pouwer F., Kupper N., Adriaanse M. C. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med: 2010; 9 45 112 118 EK III
475. Chida Y., Hamer M. An association of adverse psychosocial factors with diabetes mellitus: a meta-analytic review of longitudinal cohort studies. Diabetologia: 2008; 51 12 2168 2178 EK III
476. Polonsky W. H., Anderson B. J., Lohrer P. A. et al. Assessment of diabetes-related distress. Diab Care: 1995; 18 06 754 760 EK III
477. Odegard P. S., Gray S. L. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ: 2008; 34 04 692 697 EK III
478. Schmittdiel J. A., Uratsu C. S., Karter A. J. et al. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med: 2008; 23 05 588 594 EK III
479. Kubiak T., Hermanns N., Kulzer B. et al. Evaluation der deutschen Fassung des Problem Areas in Diabetes (PAID) Fragebogens. In: Helmes A. (Hrsg.). Lebensstiländerungen in der Prävention und Rehabilitation. Lengerich Papst: 2005; 151 EK III
480. Soo H., Lam S. Stress management training in diabetes mellitus. J Health Psychol: 2009; 14 07 933 943 EK Ib
481. Walker E. A., Usher J. A. Understanding and enhancing adherence in adults with diabetes. Curr Diab Rep: 2003; 3 02 141 148 EK Ib
482. Alam R., Sturt J., Lall R. et al. An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and generalist clinicians on glycaemic control and on psychological status. Patient Educ Couns: 2009; 75 01 25 36 EK Ia
483. Winkley K., Ismail K., Landau S. et al. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ: 2006; 333 7558 65 EK Ia
484. Henry J. L., Wilson P. H., Bruce D. G. et al. Cognitive-behavioural stress management for patients with non-insulin dependent diabetes mellitus. Psychology, Health & Medicine: 1997; 2 02 109 118 EK Ib
485. McGinnis R. A., McGrady A., Cox S. A. et al. Biofeedback-assisted relaxation in type 2 diabetes. Diab Care: 2005; 28 09 2145 2149 EK Ib
486. Surwit R. S., van Tilburg M. A., Zucker N. et al. Stress management improves long-term glycemic control in type 2 diabetes. Diab Care: 2002; 25 01 30 34 EK Ib
487. Tsujiuchi T., Kumano H., Yoshiuchi K. et al. The effect of Qi-gong relaxation exercise on the control of type 2 diabetes mellitus: a randomized controlled trial. Diab Care: 2002; 25 01 241 242 EK Ib
488. Attari A., Sartippour M., Amini M. et al. Effect of stress management training on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract: 2006; 73 01 23 28 EK IIa
489. Feinglos M. N., Hastedt P., Surwit R. S. Effects of relaxation therapy on patients with type I diabetes mellitus. Diab Care: 1987; 10 01 72 75 EK Ib
490. Jablon S. L., Naliboff B. D., Gilmore S. L. et al. Effects of relaxation training on glucose tolerance and diabetic control in type II diabetes. Appl Psychophysiol Biofeedback: 1997; 22 03 155 169 EK Ib
491. Stenström U., Göth A., Carlsson C. et al. Stress management training as related to glycemic control and mood in adults with Type 1 diabetes mellitus. Diabetes Res Clin Pract: 2003; 60 03 147 152 EK Ib
492. van Rooijen A. J., Rheeder P., Eales C. J. et al. Effect of exercise versus relaxation on haemoglobin A1C in Black females with type 2 diabetes mellitus. QJM: 2004; 97 06 343 351 EK Ib
493. Aikens J. E., Kiolbasa T. A., Sobel R. Psychological predictors of glycemic change with relaxation training in non-insulin-dependent diabetes mellitus. Psychother Psychosom: 1997; 66 06 302 306 EK IIa
494. Whalley B., Rees K., Davies P. et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev: 2011; 08 CD002902 EK Ia
495. Fosbury J. A., Bosley C. M., Ryle A. et al. A trial of cognitive analytic therapy in poorly controlled type I patients. Diab Care: 1997; 20 06 959 964 EK Ib
496. Stevens L. C. Programs and meta-programs for the control of diabetic symptomatology: A comparative treatment study. Denton, Texas, USA North Texas State University: 1983; EK IIa
497. van Dam H. A., van der Horst F. G., Knoops L. et al. Social support in diabetes: a systematic review of controlled intervention studies. Patient Educ Couns: 2005; 59 01 1 12 EK Ib
498. Anderson R. M., Funnell M. M., Butler P. M. et al. Patient empowerment. Results of a randomized controlled trial. Diab Care: 1995; 18 07 943 949 EK Ib
499. Ismail K., Thomas S. M., Maissi E. et al. Motivational enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a randomized trial. Ann Intern Med: 2008; 149 10 708 719 EK Ib
500. Karlsen B., Idsoe T., Dirdal I. et al. Effects of a group-based counselling programme on diabetes-related stress, coping, psychological well-being and metabolic control in adults with type 1 or type 2 diabetes. Patient Educ Couns: 2004; 53 03 299 308 EK Ib
501. West D. S., DiLillo V., Bursac Z. et al. Motivational interviewing improves weight loss in women with type 2 diabetes. Diab Care: 2007; 30 05 1081 1087 EK Ib
502. Pibernik-Okanovic M., Prasek M., Poljicanin-Filipovic T. et al. Effects of an empowerment-based psychosocial intervention on quality of life and metabolic control in type 2 diabetic patients. Patient Educ Couns: 2004; 52 02 193 199 EK IIb
503. Snoek F. J., van der Ven N. C., Lubach C. H. et al. Effects of cognitive behavioural group training (CBGT) in adult patients with poorly controlled insulin-dependent (type 1) diabetes: a pilot study. Patient Educ Couns: 2001; 45 02 143 148 EK IIb
504. Boehm S., Schlenk E. A., Raleigh E. et al. Behavioral analysis and behavioral strategies to improve self-management of type II diabetes. Clin Nurs Res: 1993; 2 03 327 344 EK Ib
505. Bradshaw B. G., Richardson G. E., Kumpfer K. et al. Determining the efficacy of a resiliency training approach in adults with type 2 diabetes. Diabetes Educ: 2007; 33 04 650 659 EK Ib
506. Glasgow R. E., La Chance P. A., Toobert D. J. et al. Long-term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office. Patient Educ Couns: 1997; 32 03 175 184 EK Ib
507. Gregg J. A., Callaghan G. M., Hayes S. C. et al. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J Consult Clin Psychol: 2007; 75 02 336 343 EK Ib
508. Rabkin S. W., Boyko E., Wilson A. et al. A randomized clinical trial comparing behavior modification and individual counseling in the nutritional therapy of non-insulin-dependent diabetes mellitus: comparison of the effect on blood sugar, body weight, and serum lipids. Diab Care: 1983; 6 01 50 56 EK Ib
509. Rubak S., Sandbaek A., Lauritzen T. et al. Effect of "motivational interviewingo" on quality of care measures in screen detected type 2 diabetes patients: a one-year follow-up of an RCT, ADDITION Denmark. Scand J Prim Health Care: 2011; 29 02 92 98 EK Ib
510. Snoek F. J., van der Ven N. C., Twisk J. W. et al. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled Type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet Med: 2008; 25 11 1337 1342 EK Ib
511. Welch G., Zagarins S. E., Feinberg R. G. et al. Motivational interviewing delivered by diabetes educators: does it improve blood glucose control among poorly controlled type 2 diabetes patients? Diabetes Res Clin Pract: 2011; 91 01 54 60 EK Ib
512. Williams G. C., McGregor H., Zeldman A. et al. Promoting glycemic control through diabetes self-management: evaluating a patient activation intervention. Patient Educ Couns: 2005; 56 01 28 34 EK Ib
513. Cummings S. M., Cooper R. L., McClure C. K. Motivational Interviewing to Affect Behavioral Change in Older Adults. Research on Social Work Practice: 2009; 19 02 195 204 EK Ib